Global Cooperation Group / Pharmacopoeial Discussion Group / MSSO / ICH Controlled Terminology Working Group / Gene Therapy Discussion Group / CIOMS Working Group / Biotechnology-Derived Pharmaceuticals / /
Continent
Europe / /
Country
Japan / United States / China / /
Event
Business Partnership / FDA Phase / /
IndustryTerm
pharmaceutical development / chemical experts / treatment of cancer / prescription drug products / therapy products / pharmaceutical quality / /
MedicalCondition
non-rodent chronic study duration / cancer / chronic testing duration / /
MedicalTreatment
gene therapy / oncology therapies / /
Organization
WHO Regional Office for the Eastern Mediterranean / Maintenance and Support Services Organisation for MedDRA / World Health Organization / ICH Secretariat / WHO UMC / Uppsala Monitoring Centre / International Organisation for Standardisation / Bacterial Endotoxins Chapter / International Federation of Pharmaceutical Manufacturers and Associations / General Chapter on Color / FDA / Brussels SC / MedDRA Management Board / Association of Southeast Asian Nations / European Committee for Standardisation / European Union / ICH STEERING COMMITTEE / Asia-Pacific Economic Cooperation / Council for International Organizations of Medical Sciences / /
Microsoft Word - ICH SC Summary Chicago 2006 Draft 3 with links.doc